Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1/2 1

Status

Withdrawn 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Other hematologic neoplasm 3Myeloid 2Lymphoid 2Plasma cell 1Classical hematology 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 250Leukemia 186Leukemia, Myeloid, Acute 103Myelodysplastic Syndromes 78Lymphoma 73Burkitt Lymphoma 69Leukemia, Lymphocytic, Chronic, B-Cell 49Leukemia, Myeloid, Accelerated Phase 45Lymphoma, Non-Hodgkin 44Hodgkin Disease 41Lymphoma, Large B-Cell, Diffuse 40Leukemia, Myeloid, Chronic-Phase 39Graft vs Host Disease 39Congenital Abnormalities 39Myeloproliferative Disorders 38Blast Crisis 38Lymphoma, Follicular 37Leukemia, Myelomonocytic, Chronic 37Multiple Myeloma 35Leukemia, Biphenotypic, Acute 35Lymphoma, Mantle-Cell 34Lymphoma, Large-Cell, Immunoblastic 31Lymphoma, B-Cell, Marginal Zone 31Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 30Recurrence 29Primary Myelofibrosis 25Leukemia, Myelogenous, Chronic, BCR-ABL Positive 25Anemia, Refractory, with Excess of Blasts 24Neoplasms, Plasma Cell 23Hematologic Neoplasms 23

Interventions

Cyclophosphamide 13fludarabine 11Mycophenolic Acid 9Busulfan 8fludarabine phosphate 7Tacrolimus 7pirtobrutinib 6Whole-Body Irradiation 6Rituximab 6Melphalan 6Imatinib Mesylate 5Bone Marrow Transplantation 5ponatinib 4Mesna 4Granulocyte Colony-Stimulating Factor 4Azacitidine 4venetoclax 3nilotinib 3lintuzumab 3Stem Cell Transplantation 3Sirolimus 3Platelet Transfusion 3Methotrexate 3Cytarabine 3Cyclosporine 3Alemtuzumab 3vosaroxin 2ruxolitinib 2ibrutinib 2Thiotepa 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Hematologic Diseases × Methotrexate × Other hematologic neoplasm × Clear all
NCT03842696 2026-01-27

Vorinostat for Graft vs Host Disease Prevention in Children, Adolescents and Young Adults Undergoing Allogeneic Blood and Marrow Transplantation

University of Michigan Rogel Cancer Center

Phase 1/2 Active not recruiting
43 enrolled
LymphoidMyeloidOther hematologic neoplasm

Blast Crisis, Graft vs Host Disease, Hematologic Diseases, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell

NCT04127721 2020-10-29

Itacitinib for the Prevention of Graft Versus Host Disease in Patients Undergoing Donor Stem Cell Transplantation

M.D. Anderson Cancer Center

Phase 2 Withdrawn
Other hematologic neoplasm

Hematologic Diseases, Hematologic Neoplasms

NCT00636909 2017-04-06

MINI HEME

Beth Israel Deaconess Medical Center

Phase 2 Completed
25 enrolled
Classical hematologyLymphoidMyeloidOther hematologic neoplasmPlasma cell

Anemia, Aplastic, Blast Crisis, Hematologic Diseases, Hodgkin Disease, Multiple Myeloma, Myeloproliferative Disorders, Leukemia, Myeloid, Chronic-Phase

Data powered by HemOnc (CC BY 4.0) Colophon âš¡